Founded in 2015 in Suzhou Industrial Park, SmartNuclide is a biopharmaceutical company focused on discovering and developing innovative biologics used in nuclear medicine, with its world-leading research and development technology platform for domain antibody-radiopharmaceuticals. Since inception, the company has raised several tens of millions RMB in two financing rounds from venture investors including Bohe Angel Fund, Watson Capital, Kington Capital, and Longmen Capital.
Company Details
- Employees
- 1
- Founded
- 2015
- Address
- 218 Xinghu St, Biobay A4-202,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.smartnucl.com
- Keywords
- Biopharmaceutical, Nuclear Medicine, rhTSH, Thyroid Cancer, Domain Antibody, Radiopharmaceutical.
- HQ
- Suzhou, Jiangsu
Smartnuclide Biopharma Questions
Smartnuclide Biopharma's website is http://www.smartnucl.com
Smartnuclide Biopharma's LinkedIn profile is https://cn.linkedin.com/company/smartnuclide
Smartnuclide Biopharma has
1 employees.
View email and phone details for 1
employees at Smartnuclide Biopharma.
Smartnuclide Biopharma's industry is
Pharmaceutical Manufacturing
Smartnuclide Biopharma's top competitors are
Molecular Targeting Technologies,inc,
Radiomedix, Inc.,
Alpha-9 Oncology,
Aexelar Inc.,
Life Molecular Imaging,
Recip,
Boomray Pharmaceuticals,
Radiomer Therapeutics,
Curadel Pharma,
Abdera Therapeutics.
Smartnuclide Biopharma's categories are Pharmaceutical Manufacturing
Smartnuclide Biopharma's founding year is 2015
